CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Economic impact of tuberculosis on survivors of drug sensitive TB

Author: 
Dr. Suvrojyoti Dhenki, Dr. Arup Kumar Chakrabartty and Dr. Sahanaz Begum
Subject Area: 
Health Sciences
Abstract: 

Tuberculosis (TB) imposes a substantial economic burden on survivors of drug-sensitive TB, as evidenced by the data and supported by comparative studies. The findings reveal that direct costs, including diagnostics, medicine, and transportation, significantly impact patients, despite widespread use of government healthcare facilities. These expenses, coupled with income loss and wage disruption highlight the financial instability faced by TB survivors. Prolonged recovery periods further exacerbate this burden, reducing earning potential and straining household finances. • 74% of survivors reported a loss of income, and 42% experienced job loss due to the disease. The wage loss data shows variability, with 26% reporting no loss, while 23% lost wages equivalent to 7 days, and others reported longer periods (up to 270 days). This demonstrates the severe disruption in earning capacity caused by TB, particularly for daily laborers who constitute a significant share of the employed population (52%). • Survivors incurred significant additional monthly expenses, with 52% spending ₹1000 or more on necessities related to TB management. Diagnostic and travel costs added to this burden, with 64% spending ₹100 on travel and others incurring costs as high as ₹700 for diagnostics. These recurrent expenditures, though individually modest, compound over time, leading to financial strain. • 87% of survivors reported a reduction in savings, reflecting how TB depletes financial reserves, leaving families vulnerable to economic shocks. Such financial erosion can have long-term consequences, particularly for low-income households. • Although 82% of survivors relied on government hospitals for treatment, suggesting some alleviation of direct medical costs, additional expenses for medicine (e.g., 29% incurring ₹2000) and domestic losses (e.g., 23% facing ₹100 in expenses) highlight the hidden costs of managing TB. • 79% of households experienced mild food insecurity, while 8% faced severe impacts, underlining how TB indirectly affects nutritional well-being. This reflects the trade-offs households must make between healthcare spending and essential needs.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Govindaiah Simuni
USA
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran